Search results
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 1 day agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
New COVID variant KP.3 climbs to 25%, now largest in CDC estimates
CBS News· 3 days agoThe new KP.3 variant has climbed to 1 in 4 new COVID-19 cases nationwide, the Centers for Disease...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remains trapped below a...
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 5 days agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
Pfizer: New Cancer Drugs Could Breathe New Life Into Struggling Pharma Behemoth | Investing.com PH
Investing.com· 6 days agoPharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader...
Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead
Benzinga via Yahoo Finance· 3 days agoPfizer Inc. (NYSE:PFE) has long been a favorite among income investors, thanks to its generous...
Paxlovid Doesn't Cure Long COVID
Time via Yahoo News· 2 days agoPfizer's drug Paxlovid on display in Pembroke Pines, Fla., on July 7, 2022. Credit - Joe Raedle—Getty Images Taking the COVID-19 antiviral Paxlovid does...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 2 days agoThe dividend isn't the only thing attractive about this stock Keith Speights (Pfizer): Income...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 2 days ago(Reuters) -The U.S. Food and Drug Administration approved the expanded use of GSK's respiratory...
2 Dividend Stocks Billionaires Are Buying: Should You?
Motley Fool via Yahoo Finance· 3 days agoSo should investors follow suit here? In my view, the answer is yes. True, Pfizer's revenue and net...